PRECEDEX
Drug
PFIZER INC.
Total Payments
$2.9M
Transactions
649
Doctors
236
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1,330 | 2 | 2 |
| 2023 | $648.00 | 2 | 0 |
| 2022 | $198,170 | 38 | 2 |
| 2021 | $1.2M | 196 | 4 |
| 2020 | $326,540 | 143 | 25 |
| 2019 | $32,189 | 23 | 18 |
| 2018 | $353,161 | 33 | 23 |
| 2017 | $779,570 | 212 | 174 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.7M | 297 | 94.6% |
| Consulting Fee | $121,596 | 36 | 4.2% |
| Travel and Lodging | $19,962 | 74 | 0.7% |
| Food and Beverage | $13,359 | 242 | 0.5% |
Payments by Type
Research
$2.7M
297 transactions
General
$154,918
352 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A PHASE 34 RANDOMIZED DOUBLEBLIND DOSERANGING STUDY OF THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE DEX USED WITH PROPOFOL PRO AS NEEDED FOR PROCEDURAL SEDATION OF PEDIATRIC SUBJECTS 1 MONTH TO 17 YEARS OF AGE UNDERGOING MRI SCANS | PFIZER INC. | $1.3M | 0 |
| PRE12013 PREVENTION OF ATRIAL ARRHYTHMIAS AND DELIRIUM AFTER CARDIAC SURGERY WITH DEXMEDETOMIDINE | PFIZER INC. | $737,625 | 0 |
| A PHASE 4 RANDOMIZED DOUBLEBLIND DOSERANGING STUDY OF THE EFFICACY SAFETY AND PKPD OF DEXMEDETOMIDINE DEX WHEN USED WITH PROPOFOL PRO ADMINISTERED AS NEEDED FOR PROCEDURAL SEDATION OF PEDIATRIC SUBJECTS 1 MONTH TO 17 YEARS OF AGE UNDERGOING MRI SCANS | PFIZER INC. | $285,667 | 0 |
| MAXIMIZING THE EFFICACY OF SEDATION AN REDUCING NEUROLOGICAL DYSFUNCTION AND MORTALITY IN SEPTIC PATIENTS WITH ACUTE RESPIRATORY FAILURE | PFIZER INC. | $260,400 | 0 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP STUDY OF DEXMEDETOMIDINE PRECEDEX WITH LORAZEPAM RESCUE FOR THE MANAGEMENT OF SEVERE ALCOHOL WITHDRAWAL SYNDROME AWS AND ALCOHOL WITHDRAWAL DELIRIUM AWD | PFIZER INC. | $99,877 | 0 |
| WI234564 MAXIMIZING EFFICACY OF TARGETED SEDATION AND REDUCING NEUROLOGICAL DYSFUNCTION IN MECHANICALLY VENTILATED INFANTS AND CHILDREN STUDY MINIMENDS | PFIZER INC. | $2,347 | 0 |
| DOSE ESCALATION PHARMACOKINETIC STUDY OF INTRANASAL ATOMIZED DEXMEDETOMIDINE IN PEDIATRIC PATIENTS WITH CONGENITAL HEART DISEASE | PFIZER INC. | $609.00 | 0 |
| PRECEDEX CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
Top Doctors Receiving Payments for PRECEDEX — Page 10
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Obstetrics & Gynecology | Houston, TX | $9.07 | 1 |
| , M.D | Obstetrics & Gynecology | Houston, TX | $9.07 | 1 |
| , M.D | Obstetrics & Gynecology | Houston, TX | $9.07 | 1 |
| , M.D | Specialist | Houston, TX | $9.07 | 1 |
| , MD | Specialist | Houston, TX | $9.07 | 1 |
| , MD | Obstetrics & Gynecology | Houston, TX | $9.07 | 1 |
| , M.D | Critical Care Medicine | Augusta, GA | $7.95 | 1 |
| , M.D | Family Medicine | Dayton, OH | $6.95 | 1 |
| , MD | Family Medicine | Lexington, KY | $5.55 | 1 |
| , M.D | Internal Medicine | Guayama, PR | $5.21 | 1 |
| , M.D | Nephrology | Caguas, PR | $5.21 | 1 |
| , MD, DABPM, FIPP | Interventional Pain Medicine | Bloomington, IL | $2.45 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $2.9M
- HOSPIRA, INC. $3,964
- PFIZER PHARMACEUTICALS LLC $10.42
Product Information
- Type Drug
- Total Payments $2.9M
- Total Doctors 236
- Transactions 649
About PRECEDEX
PRECEDEX is a drug associated with $2.9M in payments to 236 healthcare providers, recorded across 649 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2017 to 2024. In 2024, $1,330 was paid across 2 transactions to 2 doctors.
The most common payment nature for PRECEDEX is "Unspecified" ($2.7M, 94.6% of total).
PRECEDEX is associated with 8 research studies, including "A PHASE 34 RANDOMIZED DOUBLEBLIND DOSERANGING STUDY OF THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE DEX USED WITH PROPOFOL PRO AS NEEDED FOR PROCEDURAL SEDATION OF PEDIATRIC SUBJECTS 1 MONTH TO 17 YEARS OF AGE UNDERGOING MRI SCANS" ($1.3M).